What is Contineum Therapeutics, Inc. Class A Common Stock's Market Cap?

Contineum Therapeutics, Inc. Class A Common Stock's Market Cap is $312.6M, based on as-reported figures from SEC (XBRL) filings.

What is Contineum Therapeutics, Inc. Class A Common Stock's Enterprise Value?

Contineum Therapeutics, Inc. Class A Common Stock's Enterprise Value is $297.9M, based on as-reported figures from SEC (XBRL) filings.

What is Contineum Therapeutics, Inc. Class A Common Stock's EV / EBITDA?

Contineum Therapeutics, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Contineum Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?

Contineum Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.

What is Contineum Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?

Contineum Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -1.53, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Contineum Therapeutics, Inc. Class A Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01M27SWR2

8.31▼ 0.08 (-1.01%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 8.40
Day's Range: 8.01 – 8.43
52-Week Range: 6.73 – 17.79
Volume: 428.8K
Avg Volume: 1.2M

Share Statistics

Shares Outstanding
Employees: 51
Exchange: XNAS
Listed: 2024-04-05

Share count as of July 24, 2026

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Contineum Therapeutics, Inc. Class A Common Stock (CTNM)

What is Contineum Therapeutics, Inc. Class A Common Stock's Market Cap?: Contineum Therapeutics, Inc. Class A Common Stock's Market Cap is $312.6M, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's Enterprise Value?: Contineum Therapeutics, Inc. Class A Common Stock's Enterprise Value is $297.9M, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's EV / EBITDA?: Contineum Therapeutics, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's Net Income (TTM)?: Contineum Therapeutics, Inc. Class A Common Stock's Net Income (TTM) is -$57.6M, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's EBITDA?: Contineum Therapeutics, Inc. Class A Common Stock's EBITDA is -$66.0M, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM)?: Contineum Therapeutics, Inc. Class A Common Stock's Diluted EPS (TTM) is -1.53, based on as-reported figures from SEC (XBRL) filings.
What is Contineum Therapeutics, Inc. Class A Common Stock's Net Debt?: Contineum Therapeutics, Inc. Class A Common Stock's Net Debt is -$14.7M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · CTNMAs-filed SEC (XBRL) data